Blog
RSS FeedPosted by Michael Wonder on 17 Feb 2025
Out of pocket getting out of hand - reducing the financial toxicity of rapidly approved drugs
15 February 2025 - In 2023, Teresa was diagnosed with amyotrophic lateral sclerosis. Several months later, her family started a GoFundMe ...
Posted by Michael Wonder on 22 Sep 2024
Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines
18 September 2024 - Amid debate over potential abuse of the US patent system by the pharmaceutical industry, moves by ...
Posted by Michael Wonder on 07 Dec 2023
‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices
7 December 2023 - In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer treatment, ...
Posted by Michael Wonder on 02 Dec 2023
China’s new cancer drug toripalimab is approved in the US but will cost 30 times more
29 November 2023 - In China, a single dose vial costs US$280 but in the US it will have a wholesale ...
Posted by Michael Wonder on 08 Nov 2023
Biogen-Sage Therapeutics post partum depression pill priced at $15,900
7 November 2023 - Sage Therapeutics has priced the oral post partum depression pill it developed with partner Biogen at ...
Posted by Michael Wonder on 23 Oct 2023
Ozempic and Wegovy don’t cost what you think they do
22 October 2023 - Drug companies are making billions from a new class of in demand weight loss treatments. But the ...
Posted by Michael Wonder on 15 Jun 2023
Coherus resolves part of dispute with AbbVie over Humira biosimilar
16 June 2023 - Coherus BioSciences said on Thursday it had agreed to retract a restraining order against AbbVie as ...
Posted by Michael Wonder on 07 Jun 2023
‘We don’t agree’ on drug pricing policy, FDA chief tells biotech leaders
7 June 2023 - The drug industry has spent the past year speaking against new mechanisms that could limit how ...
Posted by Michael Wonder on 02 Jun 2023
Coherus announces industry wide lowest list price for adalimumab biosimilar Yusimry (adalimumab-aqvh) launching in July 2023
1 June 2023 - List price of $995 per carton for two 40 mg/0.8 mL auto-injectors. ...
Posted by Michael Wonder on 11 Feb 2023
State of the Union highlights America’s awkward conversation on financing the development of new medicines
9 February 2023 - Science, medicine, health care, and paying for medicines featured prominently in President Joe Biden’s State of ...
Posted by Michael Wonder on 30 Jan 2023
US law makers call on Biden Administration to lower the price of enzalutamide
27 January 2023 - US Senator Elizabeth Warren, a Democrat from Massachusetts, and nearly two dozen other lawmakers are demanding to ...
Posted by Michael Wonder on 26 Jan 2023
Patent reform and lower drug prices should be bipartisan priorities
25 January 2023 - As the 118th Congress convenes this month in Washington D.C., many pundits and advocates have little ...
Posted by Michael Wonder on 21 Jan 2023
Stop blaming Biogen for putting profit at the expense of patients. Blame the systems that enabled it.
17 January 2023 - Two congressional committees recently released damning results of an 18 month investigation into the FDA’s approval of ...
Posted by Michael Wonder on 10 Jan 2023
Moderna considers price of $110-$130 for COVID-19 vaccine
9 January 2023 - Commercial price is similar to Pfizer’s plans for after government contracting ends. ...
Posted by Michael Wonder on 07 Jan 2023
Eisai's approach to US pricing for Leqembi (lecanemab), a treatment for early Alzheimer's disease, sets forth out concept of "societal value of medicine" in relation to "price of medicine"
6 January 2023 - Maximising our value for all stakeholders while giving back value to society. ...